Osiris Therapeutics, Inc.' (JOBS) Stem Cell Drug Fails in Two Late-Stage Trials
Reuters -- Adult stem cell research firm Osiris Therapeutics Inc said two late-stage trials testing its lead product to treat a rare condition that affects bone marrow transplant patients failed to meet the main study goals.